184 related articles for article (PubMed ID: 3140453)
1. Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation.
Winde G; Dietl KH; Raidt H; Buchholz B; Lison AE; Bünte H
Transplant Proc; 1988 Oct; 20(5 Suppl 6):87-9. PubMed ID: 3140453
[No Abstract] [Full Text] [Related]
2. Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy.
Hirsch RL; Layton PC; Barnes LA; Kremer AB; Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 1):32-6. PubMed ID: 3105138
[No Abstract] [Full Text] [Related]
3. Treatment with OKT3 and cyclosporine for acute allograft rejection.
Schulak JA; Mayes JT; Hricik DE
Transplant Proc; 1991 Aug; 23(4):2119-22. PubMed ID: 1908150
[TBL] [Abstract][Full Text] [Related]
4. Orthoclone OKT3 as first-line therapy in acute renal allograft rejection.
Strate M; Jørgensen KA; Rohr N; Elbirk A; Svendsen V; Birkeland SA
Transplant Proc; 1990 Feb; 22(1):219-20. PubMed ID: 2106739
[No Abstract] [Full Text] [Related]
5. Orthoclone OKT3 treatment of acute renal allograft rejection.
Friedman J; Barnes L; Sheahan M; Tsai H; Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 2):46. PubMed ID: 3105144
[No Abstract] [Full Text] [Related]
6. Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody.
McLigeyo SO; Notghi A; Anderton JL; Dick J
East Afr Med J; 1990 Sep; 67(9):667-73. PubMed ID: 2123786
[TBL] [Abstract][Full Text] [Related]
7. Clinical development of Orthoclone OKT3.
Cosimi AB
Transplant Proc; 1987 Apr; 19(2 Suppl 1):7-16. PubMed ID: 3105142
[No Abstract] [Full Text] [Related]
8. Use of OKT3 in kidney, pancreas, and liver transplantation.
D'Alessandro AM; Pirsch JD; Melzer JS; Sollinger HW; Kalayoglu M; Reed A; Knechtle SJ; Belzer FO
Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
[No Abstract] [Full Text] [Related]
9. Orthoclone OKT3 as rescue treatment for steroid-resistant and recurrent acute rejection in clinical renal transplantation.
Tvedegaard E; Olgaard K
Transplant Proc; 1990 Feb; 22(1):217-8. PubMed ID: 2106738
[No Abstract] [Full Text] [Related]
10. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
Monaco A; Goldstein G; Barnes L
Transplant Proc; 1987 Apr; 19(2 Suppl 1):28-31. PubMed ID: 3105137
[No Abstract] [Full Text] [Related]
11. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
Widmer U; Frei D; Keusch G; Burger HR; Largiader F; Binswanger U
Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454
[No Abstract] [Full Text] [Related]
12. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
Prieto C; Rodriguez-Paternina E; Andrés A; Morales JM; Farias J; Montoyo C; Regueiro JR; Rodicio JL
Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
[No Abstract] [Full Text] [Related]
13. [Neurologic complications induced by the treatment of the acute renal allograft rejection with the monoclonal antibody OKT3].
Fernández O; Romero F; Bravo M; Burgos D; Cabello M; González-Molina M
Neurologia; 1993 Oct; 8(8):277-80. PubMed ID: 8240843
[TBL] [Abstract][Full Text] [Related]
14. Comparison between prophylactic use of OKT3 and cyclosporine in cadaveric renal transplantation.
De Pauw L; Abramowicz D; Goldman M; Vereerstraeten P; Kinnaert P; Toussaint C
Transplant Proc; 1990 Aug; 22(4):1759-60. PubMed ID: 2117800
[No Abstract] [Full Text] [Related]
15. The treatment of steroid-resistant renal allograft rejection with OKT3 and plasmapheresis.
Haberal M; Sert S; Gülay H; Arslan G; Bilgin N
Transplant Proc; 1990 Aug; 22(4):1761-3. PubMed ID: 2117801
[No Abstract] [Full Text] [Related]
16. Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection.
Lucas BA; Waid TH; Thompson JS; Brown SA; Munch LC; McKeown JW; Kryscio RJ; Prebeck RJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):543-5. PubMed ID: 8438406
[No Abstract] [Full Text] [Related]
17. The prophylactic use of Orthoclone OKT3 in kidney and heart transplantation.
Weimar W; Baumgartner D; Hendriks GF; Hesse CJ; Balk AH; Simoons ML; Bos E
Transplant Proc; 1988 Oct; 20(5 Suppl 6):96-100. PubMed ID: 3140455
[No Abstract] [Full Text] [Related]
18. Pilot study on induction treatment with high-dose OKT3: preliminary observations in kidney transplantation.
Welter HF; Illner WD; Schleibner S; Abendroth D; Hancke E; Groh J; Land W
Transplant Proc; 1990 Oct; 22(5):2272. PubMed ID: 2120813
[No Abstract] [Full Text] [Related]
19. [Orthoclone OKT3 in the treatment of intractable acute renal allograft rejection].
Yu LX
Zhonghua Wai Ke Za Zhi; 1993 Dec; 31(12):754-5. PubMed ID: 8033708
[TBL] [Abstract][Full Text] [Related]
20. Immunologic monitoring in OKT3-treated kidney graft recipients.
Zlabinger GJ; Maurer D; Ulrich W; Meron G; Pohanka E; Kovarik J
Transplant Proc; 1990 Aug; 22(4):1777-8. PubMed ID: 2117807
[No Abstract] [Full Text] [Related]
[Next] [New Search]